Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Features THT 2023

The Promise of AI for Improving Health Equity in Heart Failure

Todd Neale

April 04, 2023

News Conference News THT 2023

More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field

Shelley Wood

March 24, 2023

News Conference News THT 2023

High-Intensity Care After Acute HF Pays Off Across LVEF Spectrum: STRONG-HF

Todd Neale

March 23, 2023

News Conference News THT 2023

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Yael L. Maxwell

March 22, 2023

Presentation THT 2023

TMVR Clinical Trials: Ready for Prime Time or Stuck in the Mud?

Presenter: Martin Leon

March 22, 2023

News Conference News THT 2023

Pulmonary Artery Denervation Makes Inroads in PAH Due to Left-Sided HF

Shelley Wood

March 21, 2023

Presentation THT 2023

Engaging Patients and Clinicians With Remote Pulmonary Artery Pressures Improves Care: A Sub-study of the PROACTIVE-HF Clinical Trial

Presenter: Jason Guichard

March 21, 2023

Presentation THT 2023

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: Updated Results of the REBALANCE-HF Trial Roll-in Cohort

Presenter: Marat Fudim

March 21, 2023

Presentation THT 2023

Long-Term Improvement in Clinical Outcome in Patients With Combined Pre- and Post-Capillary Pulmonary Hypertension: 3-Year Analysis From PADN-5 Trial

Presenter: Dongming Hou

March 21, 2023

Presentation THT 2023

Left Ventricular Ejection Fraction and Intensive Up-Titration of Oral Treatment in Patients Recently Hospitalized for Heart Failure: Insights From the STRONG-HF Trial

Presenter: Matteo Pagnesi

March 21, 2023

News Conference News THT 2023

Higher Gradient After Tricuspid TEER Not Harmful at 1 Year: TriValve Registry

Caitlin E. Cox

March 21, 2023

Presentation THT 2023

Pulmonary Denervation Treatment of Pulmonary Hypertension Group II Study (TROPHY-II) Trial

Presenter: Greg Lewis

March 21, 2023

News Conference News THT 2023

PCI’s Role for Patients With HFrEF and Extensive CAD: Experts Debate

Todd Neale

March 20, 2023

Presentation THT 2023

FDA Guidance on Meaningful Representation in Clinical Trials

Presenter: Bram Zuckerman

March 20, 2023

Presentation THT 2023

How Tightly Should Treatment Algorithms Be Prescribed in a Clinical Trial Considering Best-Practices & Escalation of Therapy? What Are The Key Treatment Protocol Elements?

Presenter: Navin Kapur

March 20, 2023

Presentation THT 2023

How Narrow or Broad Should Trial Enrollment Criteria Be to Achieve Clinically Interpretable Results? (STEMI vs NSTEMI; RV vs. LV vs. LV&RV Shock; AMI-CS vs Chronic HF-CS)

Presenter: Gregg Stone

March 20, 2023

Presentation THT 2023

What Are Clinically Meaningful and Practical Pivotal Trial Endpoints for Effectiveness and Safety to Demonstrate an Acceptable Benefit-Risk Profile?

Presenter: Maria Rosa Costanzo

March 20, 2023

Presentation THT 2023

SEISMiC Trial: Isatroxime (lusi-inotrope) (HF shock)

Presenter: Alexandre Mebazaa

March 20, 2023

Presentation THT 2023

SSO2 for AMI Shock: The ISO-Shock Trial (AMI)

Presenter: Babar Basir

March 20, 2023

Advertisement

The Promise of AI for Improving Health Equity in Heart Failure

More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field

High-Intensity Care After Acute HF Pays Off Across LVEF Spectrum: STRONG-HF

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

TMVR Clinical Trials: Ready for Prime Time or Stuck in the Mud?

Pulmonary Artery Denervation Makes Inroads in PAH Due to Left-Sided HF

Engaging Patients and Clinicians With Remote Pulmonary Artery Pressures Improves Care: A Sub-study of the PROACTIVE-HF Clinical Trial

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: Updated Results of the REBALANCE-HF Trial Roll-in Cohort

Long-Term Improvement in Clinical Outcome in Patients With Combined Pre- and Post-Capillary Pulmonary Hypertension: 3-Year Analysis From PADN-5 Trial

Left Ventricular Ejection Fraction and Intensive Up-Titration of Oral Treatment in Patients Recently Hospitalized for Heart Failure: Insights From the STRONG-HF Trial

Higher Gradient After Tricuspid TEER Not Harmful at 1 Year: TriValve Registry

Pulmonary Denervation Treatment of Pulmonary Hypertension Group II Study (TROPHY-II) Trial

PCI’s Role for Patients With HFrEF and Extensive CAD: Experts Debate

FDA Guidance on Meaningful Representation in Clinical Trials

How Tightly Should Treatment Algorithms Be Prescribed in a Clinical Trial Considering Best-Practices & Escalation of Therapy? What Are The Key Treatment Protocol Elements?

How Narrow or Broad Should Trial Enrollment Criteria Be to Achieve Clinically Interpretable Results? (STEMI vs NSTEMI; RV vs. LV vs. LV&RV Shock; AMI-CS vs Chronic HF-CS)

What Are Clinically Meaningful and Practical Pivotal Trial Endpoints for Effectiveness and Safety to Demonstrate an Acceptable Benefit-Risk Profile?

SEISMiC Trial: Isatroxime (lusi-inotrope) (HF shock)

SSO2 for AMI Shock: The ISO-Shock Trial (AMI)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content